Radioimmunotherapy consolidation and rituximab maintenance in the initial treatment of follicular lymphoma

Several reports have documented similar efficacies and tolerable toxicities of radioimmunotherapy (RIT) consolidation and rituximab maintenance after initial R-chemotherapy of follicular lymphoma. The relative merits of these two interventions are currently under discussion. We now raise the questio...

Descripción completa

Detalles Bibliográficos
Autores principales: Buchegger, Franz, Press, Oliver W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer 2011
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3251040/
https://www.ncbi.nlm.nih.gov/pubmed/22214546
http://dx.doi.org/10.1186/2191-219X-1-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3251040/
https://www.ncbi.nlm.nih.gov/pubmed/22214546
http://dx.doi.org/10.1186/2191-219X-1-7

Ejemplares similares